Vanguard Group Inc - Mar 31, 2025 SCHEDULE 13G/A Report for Kymera Therapeutics Inc Common Stock (KYMR)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Kymera Therapeutics Inc Common Stock
Symbol: KYMR
Shares outstanding: 65M shares
Disclosed Ownership: 5.23M shares
Ownership: 8.05%
Form type: SCHEDULE 13G/A
Date filed: 4/30/2025, 11:12 AM
Date of event: Mar 31, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	8.05%	5.23M	0	52.5K	Ashley Grim	Head of Global Fund Administration